A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
Published in: Blood
Date of publication: July 11, 2008
Language: English
Main subject: thrombosis, patient, deep vein thrombosis
Bibliographic databases:
Cites articles
There is nothing here
Article -